Picture of Bionime logo

4737 Bionime Cashflow Statement

0.000.00%
tw flag iconLast trade - 00:00
HealthcareConservativeSmall CapMomentum Trap

Annual cashflow statement for Bionime, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line13531.174.686.5-31.9
Depreciation
Amortisation
Non-Cash Items57.358.910.671.312.2
Unusual Items
Other Non-Cash Items
Changes in Working Capital49.2-35.929.9-16959.7
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities406218270142203
Capital Expenditures-138-296-285-313-441
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items8.98-34.4-3.50.6656.14
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-129-331-288-312-435
Financing Cash Flow Items20.3930.557-0.071-1.08
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-33896.3-69.3114420
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-74.1-16.3-90.2-38.6177